Bausch Health Companies Inc. (BHC) News

Bausch Health Companies Inc. (BHC): $7.30

0.13 (+1.81%)

POWR Rating

Component Grades








Filter BHC News Items

BHC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BHC News Highlights

  • For BHC, its 30 day story count is now at 15.
  • Over the past 28 days, BHC's stories per day has been in a clear downtrend, falling by about 0.07 per 2 days.
  • The most mentioned tickers in articles about BHC are TEVA, AVAH and EHC.

Latest BHC News From Around the Web

Below are the latest news stories about BAUSCH HEALTH COMPANIES INC that investors may wish to consider to help them evaluate BHC as an investment opportunity.

Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day

BRIDGEWATER, NJ / ACCESSWIRE / December 5, 2023 / Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders ...

Yahoo | December 5, 2023

Humana (HUM) Extends CINQCARE's Home Care Model to MA Members

Humana (HUM) teams up with CINQCARE to offer better health outcomes for its Medicare Advantage members of New York.

Yahoo | December 1, 2023

Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?

Here is how Bausch Health (BHC) and Gracell Biotechnologies Inc. Sponsored ADR (GRCL) have performed compared to their sector so far this year.

Yahoo | November 30, 2023

5 Canadian stocks that have been complete disasters — and what investors can learn from them

Peter Hodson: Looking for clues on where these companies went wrong could help future stock picks

Yahoo | November 29, 2023

Wall Street Analysts Believe Bausch (BHC) Could Rally 38.28%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 38.3% in Bausch (BHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | November 24, 2023

Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bausch + Lomb fair value estimate is US$25.50 Current share...

Yahoo | November 21, 2023

Encompass Health (EHC) Opens Hospital to Boost Presence in Texas

Encompass Health (EHC) opens an inpatient rehabilitation hospital in Prosper to address the diversified needs of the greater Dallas area residents. It marks EHC's 160th nationwide facility.

Yahoo | November 15, 2023

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?

Here is how Aveanna Healthcare (AVAH) and Bausch Health (BHC) have performed compared to their sector so far this year.

Yahoo | November 14, 2023

TEVA, Royalty Pharma Sign Funding Deal for Schizophrenia Drug

Per the deal, Royalty Pharma is set to provide TEVA R&D funding support of up to $125 million to develop olanzapine LAI for treating schizophrenia.

Yahoo | November 14, 2023

UnitedHealth (UNH) Unit Makes Insulin More Affordable to Avail

UnitedHealth Group's (UNH) sub-unit, Optum Rx, resorts to product shift within its formulary and makes the vital medication of insulin cost-effective, thereby boosting patients' access to it.

Yahoo | November 13, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!